Randomised controlled trial of memantine for dementia associated with Parkinson's disease

被引：0
|
作者：
Leroi, I.
Overshott, R.
Danial, E.
Byrne, E. J.
Burns, A.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
600
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [41] Rivastigmine for dementia associated with Parkinson's disease
    Emre, M
    Aarsland, D
    Albanese, A
    Byrne, EJ
    Deuschl, G
    De Deyn, PP
    Durif, F
    Kulisevsky, J
    van Laar, T
    Lees, A
    Poewe, W
    Robillard, A
    Rosa, MM
    Wolters, E
    Quarg, P
    Tekin, S
    Lane, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (24): : 2509 - 2518
  • [42] Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
    Moreau, Caroline
    Delval, Arnaud
    Tiffreau, Vincent
    Defebvre, Luc
    Dujardin, Kathy
    Duhamel, Alain
    Petyt, Gregory
    Hossein-Foucher, Claude
    Blum, David
    Sablonniere, Bernard
    Schraen, Susanna
    Allorge, Delphine
    Destee, Alain
    Bordet, Regis
    Devos, David
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2013, 84 (05): : 552 - 555
  • [43] Cognitive rehabiliation for Parkinson's disease dementia: a study protocol for a pilot randomised controlled trial (vol 18, Pg 138, 2017)
    Hindle, John V.
    Watermeyer, Tamlyn J.
    Roberts, Julie
    Martyr, Anthony
    Lloyd-Williams, Huw
    Brand, Andrew
    Gutting, Petra
    Hoare, Zoe
    Edwards, Rhiannon Tudor
    Clare, Linda
    [J]. TRIALS, 2017, 18
  • [44] Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study
    Stubendorff, Kajsa
    Larsson, Victoria
    Ballard, Clive
    Minthon, Lennart
    Aarsland, Dag
    Londos, Elisabet
    [J]. BMJ OPEN, 2014, 4 (07):
  • [45] Cholinesterase inhibitors and memantine for Parkinson's disease dementia and Lewy body dementia: A meta-analysis
    Meng, Yan-Hong
    Wang, Pan-Pan
    Song, Ya-Xue
    Wang, Jian-Hua
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (03) : 1611 - 1624
  • [46] Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
    Wang, Hui-Fu
    Yu, Jin-Tai
    Tang, Shao-Wen
    Jiang, Teng
    Tan, Chen-Chen
    Meng, Xiang-Fei
    Wang, Chong
    Tan, Meng-Shan
    Tan, Lan
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2015, 86 (02): : 135 - 143
  • [47] Memantine (Namenda) for non-motor features of Parkinson's disease: A double blind placebo controlled trial
    Ondo, W. G.
    Shinawi, L.
    Davidson, A.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S254 - S254
  • [48] Memantine improves goal attainment and reduces caregiver burden in Parkinson's disease with dementia
    Leroi, Iracema
    Atkinson, Richard
    Overshott, Ross
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2014, 29 (09) : 899 - 905
  • [49] Use of memantine (akatinol) for the correction of cognitive impairments in parkinson's disease complicated by dementia
    Litvinenko I.V.
    Odinak M.M.
    Mogil'Naya V.I.
    Perstnev S.V.
    [J]. Neuroscience and Behavioral Physiology, 2010, 40 (2) : 149 - 155
  • [50] Comparison of virtual reality rehabilitation and conventional rehabilitation in Parkinson's disease: a randomised controlled trial
    Pazzaglia, C.
    Imbimbo, I.
    Tranchita, E.
    Minganti, C.
    Ricciardi, D.
    Lo Monaco, R.
    Parisi, A.
    Padua, L.
    [J]. PHYSIOTHERAPY, 2020, 106 : 36 - 42
12345